Correlation Between Collplant Biotechnologies and Evogene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collplant Biotechnologies and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collplant Biotechnologies and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collplant Biotechnologies and Evogene, you can compare the effects of market volatilities on Collplant Biotechnologies and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collplant Biotechnologies with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collplant Biotechnologies and Evogene.

Diversification Opportunities for Collplant Biotechnologies and Evogene

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Collplant and Evogene is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Collplant Biotechnologies and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Collplant Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collplant Biotechnologies are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Collplant Biotechnologies i.e., Collplant Biotechnologies and Evogene go up and down completely randomly.

Pair Corralation between Collplant Biotechnologies and Evogene

Given the investment horizon of 90 days Collplant Biotechnologies is expected to generate 0.79 times more return on investment than Evogene. However, Collplant Biotechnologies is 1.27 times less risky than Evogene. It trades about -0.01 of its potential returns per unit of risk. Evogene is currently generating about -0.03 per unit of risk. If you would invest  821.00  in Collplant Biotechnologies on August 30, 2024 and sell it today you would lose (396.15) from holding Collplant Biotechnologies or give up 48.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Collplant Biotechnologies  vs.  Evogene

 Performance 
       Timeline  
Collplant Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collplant Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Evogene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Collplant Biotechnologies and Evogene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collplant Biotechnologies and Evogene

The main advantage of trading using opposite Collplant Biotechnologies and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collplant Biotechnologies position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.
The idea behind Collplant Biotechnologies and Evogene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal